Jeremy M Shefner, MD, PhD

Jeremy M Shefner, MD, PhD
Appointed 10/21/96
815 Jacobsen Hall
175 Elizabeth Blackwell Street
Syracuse, NY 13210

315 464-8668

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Neurology: Neuromuscular

Research Programs and Affiliations

  • Neurology
  • Neuroscience Program

Clinic/Unit

Education & Fellowships

  • Fellowship: Harvard Medical School, 1990, Clinical Neurophysiology
  • Residency: Harvard Medical School, 1988
  • Residency: Beth Israel Hospital, 1984
  • MD: Northwestern University Medical School, 1983
  • PhD: University of Illinois at Chicago, 1976

Previous Appointments

  • Brigham and Women's Hospital, 1990–1996

Clinical Interests

  • I direct the MDA/ALS Research and Treatment Center and the ALS Association sponsored ALS Clinic at University Hospital where patients with ALS are treated by a multidisciplinary clinical team. I am also interested in the electrodiagnosis and treatment of patients with a variety of neuromuscular disorders.

Research Interests

  • Clinical Therapeutics of ALS and other motor neuron disorders.  Animals models of the physiology and treatment of amyotrophic lateral sclerosis (ALS); Peripheral nerve physiology.

Specialties & Certification

  • Clinical Neurophysiology
  • Neurology

Diseases & Conditions Treated

  • Lou Gehrig's Disease

Treats

  • Adults

Treatments/Services

  • Botulinum Toxin Injections

Associations/Memberships

  • ALS Association (ALSA)
  • American Neurological Association
  • American Academy of Neurology (AAN)

Current Hospital Privileges

  • Upstate University Hospital

HealthLinkOnAir Radio Interview

9/19/10 Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease.

Publications

Link to PubMed (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

 

Therapeutic Trials in Patients with ALS.

With Dr. Merit Cudkowicz of Massachusetts General Hospital, I am co Chair of the Northeast ALS Clinical Trials Consortium (NEALS). NEALS is the largest ALS research consortium in the world, consisting of 97 clinical trial sites in the US and Canada.  We have performed 8 clinical trials in the last 10 years, and are currently involved in 5 ongoing trials.  I am co-principal investigator of the NIH funded trial of Ceftriaxone in ALS, and am the lead investigator in the ongoing development of a fast skeletal muscle activator in collaboration with Cytokinetics, Inc.  NEALS has established a significant clinical trials infrastructure, including cores for clinical trial management, an electronic data capture system, data management, outcomes measure training, and clinical monitoring cores.  These are distributed between Upstate Medical University and Massachusetts General Hospital in Boston, MA.

Studies of  motor units in patients with ALS and other motor neuron diseases

 

 I have developed a new method for the non-invasive assessment of motor units in patients with ALS and other motor neuron disorders.  The first analysis of patients with ALS using this method has recently been published in Neurology.  This method is now being employed in multicenter trials of patients with ALS and Spinal Muscular Atrophy.  I am responsible for training and validation of sites, and expect that these studies will both provide valuable insight into the pattern of motor neuron loss in these diseases, as well as provide a sensitive marker of therapeutic efficacy.

 

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/shefnerj
Faculty Profile Shortcut: http://www.upstate.edu/faculty/shefnerj
Sue Stearns in anatomy lab

Sue Stearns, PhD, is an associate professor of cell and developmental biology, and one of four faculty members who teach Gross Anatomy to first-year medical students at SUNY Upstate. Students routinely cite this course as a favorite.

Read more about Stearns' take on our Anatomy course's popularity.